Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

NCT00952341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting (CINV)

Interventions

DRUG: aprepitant
DRUG: Comparator: Placebo to aprepitant
DRUG: dexamethasone
DRUG: granisetron
DRUG: dexamethasone

Sponsor

Merck Sharp & Dohme LLC